Double-stranded ribonucleic acid with increased effectiveness in an organism
Details for Australian Patent Application No. 2009201091 (hide)
International Classifications
Event Publications
2 April 2009 Complete Application Filed
9 April 2009 Application Open to Public Inspection
Published as AU-B-2009201091
8 December 2011 Application Accepted
Published as AU-B-2009201091
2 February 2012 Corrigenda
Applications Accepted - Name Index Under the name Alnylam Pharmaceuticals, Inc., Application No. 2009201091 under INID (72) correct the co-inventor to Hadwiger, Phillipp
5 April 2012 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2009201092-Developing device, process cartridge, image forming device, and developer container
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser